Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP654692.RAw6-jLRqnvY9jlVtUbue9lpsbDl8SHa7iDOxXpCminu8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP654692.RAw6-jLRqnvY9jlVtUbue9lpsbDl8SHa7iDOxXpCminu8130_assertion type Assertion NP654692.RAw6-jLRqnvY9jlVtUbue9lpsbDl8SHa7iDOxXpCminu8130_head.
- NP654692.RAw6-jLRqnvY9jlVtUbue9lpsbDl8SHa7iDOxXpCminu8130_assertion description "[Because combined treatment also augmented the bystander cell kill, the addition of TRAIL may increase the efficacy of TK/GCV gene therapy of neuroblastoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP654692.RAw6-jLRqnvY9jlVtUbue9lpsbDl8SHa7iDOxXpCminu8130_provenance.
- NP654692.RAw6-jLRqnvY9jlVtUbue9lpsbDl8SHa7iDOxXpCminu8130_assertion evidence source_evidence_literature NP654692.RAw6-jLRqnvY9jlVtUbue9lpsbDl8SHa7iDOxXpCminu8130_provenance.
- NP654692.RAw6-jLRqnvY9jlVtUbue9lpsbDl8SHa7iDOxXpCminu8130_assertion SIO_000772 11960288 NP654692.RAw6-jLRqnvY9jlVtUbue9lpsbDl8SHa7iDOxXpCminu8130_provenance.
- NP654692.RAw6-jLRqnvY9jlVtUbue9lpsbDl8SHa7iDOxXpCminu8130_assertion wasDerivedFrom befree-20140225 NP654692.RAw6-jLRqnvY9jlVtUbue9lpsbDl8SHa7iDOxXpCminu8130_provenance.
- NP654692.RAw6-jLRqnvY9jlVtUbue9lpsbDl8SHa7iDOxXpCminu8130_assertion wasGeneratedBy ECO_0000203 NP654692.RAw6-jLRqnvY9jlVtUbue9lpsbDl8SHa7iDOxXpCminu8130_provenance.